Adaptimmune Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADAP and other ETFs, options, and stocks.

About ADAP

Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. 

CEO
Adrian Rawcliffe
CEOAdrian Rawcliffe
Employees
506
Employees506
Headquarters
Abingdon, Oxfordshire
HeadquartersAbingdon, Oxfordshire
Founded
2014
Founded2014
Employees
506
Employees506

ADAP Key Statistics

Market cap
60.28M
Market cap60.28M
Price-Earnings ratio
-0.81
Price-Earnings ratio-0.81
Dividend yield
—
Dividend yield—
Average volume
2.58M
Average volume2.58M
High today
$0.2387
High today$0.2387
Low today
$0.2128
Low today$0.2128
Open price
$0.2253
Open price$0.2253
Volume
600.17K
Volume600.17K
52 Week high
$1.48
52 Week high$1.48
52 Week low
$0.1951
52 Week low$0.1951

ADAP News

TipRanks 12h
Adaptimmune Therapeutics CFO Departure Terms Revised

The latest announcement is out from Adaptimmune Therapeutics ( (ADAP) ). Adaptimmune Therapeutics announced a variation to the previously agreed termination te...

Analyst ratings

56%

of 9 ratings
Buy
55.6%
Hold
33.3%
Sell
11.1%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.